Only one person in the trial started with a BMI of less than 24.9, the researchers said
Less water means higher concentration, fewer units per dose, but harder precision
I knew that this was just the beginning and that with continued use of Semaglutide and a healthy lifestyle, I could achieve my weight loss goals
Notably, the 2024 FDA approval of Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease and obesity/overweight (based on the SELECT trial) provides additional evidence of cardiometabolic benefits beyond glycemic control
Considering the perks that come with it, this is a highly competitive price
Type 2 Diabetes: Semaglutide (Ozempic) was first approved by the FDA in December 2017 as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus